Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Beone Medicines Ltd. (ONC) AI Forecast

Our AI analyzed Beone Medicines Ltd.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$ONC Neutral Signal Full forecast available
Sign Up Free

Beone Medicines Ltd. (ONC) Stock Forecast 2025

Beone Medicines Ltd. (ONC) AI Stock Price Forecast & Investment Analysis

Beone Medicines Ltd. Stock Price Chart and Technical Analysis

Loading chart...

Beone Medicines Ltd. (ONC) - Comprehensive Stock Analysis & Investment Research

Deep dive into Beone Medicines Ltd.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 11:01 p.m. (UTC)

Beone Medicines Ltd. Investment Summary

When evaluating whether Beone Medicines Ltd. (ONC) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Beone Medicines Ltd. (ONC) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $34 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Beone Medicines Ltd.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Beone Medicines Ltd. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Beone Medicines Ltd. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Beone Medicines Ltd.

Sign Up Free
Corporate Identity

Beone Medicines Ltd. (Stock Symbol: ONC) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Beone Medicines Ltd.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Beone Medicines Ltd....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Beone Medicines Ltd....

Unlock Full Company Profile

Get complete details about Beone Medicines Ltd.

Sign Up Free
Revenue & Growth Analysis

Beone Medicines Ltd. generates annual revenues of $6 billion , indicating a well-established business with proven market demand.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Beone Medicines Ltd....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Beone Medicines Ltd....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Beone Medicines Ltd....

Unlock Financial Analysis

Get complete financial metrics for Beone Medicines Ltd.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Beone Medicines Ltd.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Beone Medicines Ltd. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Beone Medicines Ltd. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company demonstrates exceptional operational efficiency through free cash flow generation of $1 billion annually . This substantial cash generation capability provides significant strategic flexibility for acquisitions, share repurchases, dividend growth, or debt reduction—all while maintaining operational investments necessary to defend market position.

Asset Utilization Efficiency

Asset turnover ratio of 0.67x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Beone Medicines Ltd. (ONC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Beone Medicines Ltd. stock analysis.

Deep dive into Beone Medicines Ltd.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Beone Medicines Ltd. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Beone Medicines Ltd.: With a P/E ratio of 65.91, the market highly values future growth prospects.

P/E Ratio 65.91x
P/B Ratio 7.10x
Market Cap $33.81B
Book Value/Share $45.88
Revenue/Share $55.32
FCF/Share $10.74
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Beone Medicines Ltd. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Beone Medicines Ltd.: An ROE of -1.9% indicates room for improvement in shareholder value creation.

ROE -1.9%
ROA -1.0%
Operating Margin -3003.6%
Net Margin -3249.8%
EBT Margin -3243.3%
Tax Rate -0.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Beone Medicines Ltd.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Beone Medicines Ltd.:

D/E Ratio 0.80x
Financial Leverage 1.80x
Interest Coverage 15.1x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Beone Medicines Ltd.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Beone Medicines Ltd.: Free cash flow of $1115M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow -$79M
Free Cash Flow $1.11B
Capital Spending $1.19B
FCF/Sales 19.4%
CapEx/Sales 20.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Beone Medicines Ltd. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Beone Medicines Ltd.: An asset turnover of 0.67x suggests room for improvement in asset utilization.

Asset Turnover 0.67x
Understanding Financial Statement Data

What these metrics mean: Key figures from Beone Medicines Ltd.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Beone Medicines Ltd.: With annual revenue of $5739M, Beone Medicines Ltd. operates at significant scale.

Income Statement
Total Revenue $5.74B
Operating Income -$81M
Net Income -$88M
R&D Expense $72M
Balance Sheet Highlights (% Of Assets)
Total Liabilities 3793%
Dividend & Shareholder Information
Shares Outstanding 104M
Growth Metrics (YoY)
Net Income Growth -3249.8%

Latest Beone Medicines Ltd. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Beone Medicines Ltd. (ONC) stock price and investment outlook.

📰 Loading...

Beone Medicines Ltd. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Beone Medicines Ltd. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD ██% $140M x 1.6x
ABBV ██% $466.15B 128.2x x
ABCL ██% $1.61B x 1.7x
ABEO ██% $342M 5.2x 2.4x
ABT ██% $186.84B 29.8x 3.6x
ABUS ██% $869M 5.4x 3.3x
ABVC ██% $27M x 2.5x
ABVX ██% $9.76B x x
ACAD ██% $4.45B 11.9x 3.6x
ACET ██% $77M x 0.6x
ACRS ██% $744M x 5.2x
ACRV ██% $60M x 0.6x
ACUT ██% $4M x x
ACXP ██% $6M x 0.9x
ADAG ██% $246M x 6.5x
ADCT ██% $141M x x
ADIL ██% $6M x 1.7x
ADTX ██% $3M x x
ADXN ██% $7M x x
AEON ██% $11M x x
AGIO ██% $2.14B x 1.9x
AKBA ██% $340M x 12.4x
AKTX ██% $15M x 1.0x
ALDX ██% $95M x 2.3x
ALKS ██% $8.46B 128.0x 4.7x
ALLR ██% $19M x 2.7x
ALMS ██% $3.38B x 6.0x
ALNY ██% $38.18B 121.7x 48.4x
ALT ██% $581M x 2.1x
ALXO ██% $268M x 1.8x
ALZN ██% $5M x 6.8x
AMLX ██% $2.17B x 8.0x
AMPH ██% $899M 11.4x 1.2x
AMRN ██% $293M x 0.7x
AMRX ██% $5.93B 48.6x x
ANAB ██% $1.51B x 118.7x
ANEB ██% $14M x 1.7x
ANIP ██% $1.69B 18.4x 3.0x
ANIX ██% $119M x 8.3x
ANNX ██% $757M x 3.7x
ANRO ██% $961M x 4.0x
ANTX ██% $169M x 2.1x
ANVS ██% $72M x 23.0x
APLM ██% $40M x x
APRE ██% $7M x 0.2x
APUS ██% $12M x 0.1x
APVO ██% $5M x 0.4x
AQST ██% $467M x x
ARCT ██% $163M x 0.9x
ARDX ██% $1.26B x 8.5x
ARQT ██% $3.55B x 18.7x
ARTL ██% $3M x 0.5x
ARVN ██% $529M x 1.4x
ARWR ██% $12.06B x 19.6x
ASBP ██% $9M x 2.4x
ASMB ██% $507M x 2.6x
ASND ██% $15.77B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.66B x 16.6x
ATHE ██% $83M x x
ATNM ██% $27M x 11.8x
ATOS ██% $24M x 0.8x
ATXI ██% $990K x 0.8x
AUPH ██% $1.96B 6.6x 3.5x
AVBP ██% $1.36B x 4.2x
AVIR ██% $361M x 1.5x
AVTX ██% $1.03B x 15.1x
AXIM ██% $1M x x
AXSM ██% $12.04B x 220.6x
AZTR ██% $2M x 0.2x
BBIO ██% $16.74B x x
BBOT ██% $688M x 1.9x
BCAX ██% $1.76B x 3.4x
BCTX ██% $30M x 1.3x
BCYC ██% $275M x 0.5x
BDPT ██% $30K x x
BDRX ██% $1M x x
BFRG ██% $11M x 2.2x
BFRI ██% $13M x 2.2x
BHC ██% $1.69B x x
BHST ██% $46M x 1.8x
BIOA ██% $973M x 2.6x
BIOE ██% $13M 9.7x x
BIOM ██% $380K x x
BIVI ██% $10M x 0.6x
BIXT ██% $3M x x
BLRX ██% $13M x x
BLTE ██% $6.14B x 8.0x
BMEA ██% $90M x 4.8x
BMRN ██% $11.65B 43.3x 1.9x
BMY ██% $129.62B 17.8x 6.5x
BNTC ██% $414M x 2.3x
BOLD ██% $56M x 0.6x
BOLT ██% $8M x 0.4x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $25M x 0.4x
BSPK ██% $10K x x
BTAI ██% $27M x x
BYSI ██% $48M x x
CALC ██% $11M x x
CANF ██% $7M x 1.2x
CAPR ██% $403M x 1.5x
CATX ██% $322M x 0.9x
CBIO ██% $626M x 6.2x
CDT ██% $2M x x
CING ██% $61M x 3.2x
CLCS ██% $65M x x
CLNN ██% $64M x x
CLRB ██% $20M x 5.9x
CLSDQ ██% $1M x x
CLYM ██% $732M x 5.0x
CMMB ██% $10M x 0.8x
CMND ██% $2M x x
CMPS ██% $1.52B x 4.7x
CNBX ██% N/A x x
CNSP ██% $7M x 104.8x
CNTA ██% $6.27B x 12.9x
CNTB ██% $132M x 3.1x
CNTX ██% $57M x 1.1x
COCP ██% $13M x 3.2x
COGT ██% $6.91B x 11.4x
COLL ██% $1.16B 15.5x 3.7x
CORT ██% $9.52B 201.0x 14.9x
COYA ██% $100M x 2.0x
CPHI ██% $50M x 1.4x
CPIX ██% $103M x 4.8x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $161M x 1.3x
CRMD ██% $596M 3.3x 1.4x
CRNX ██% $8.83B x 6.9x
CRVO ██% $25M x 2.3x
CRVS ██% $1.09B x 4.5x
CTMX ██% $708M x 2.2x
CTNM ██% $518M x 2.1x
CTOR ██% $52M x 1.5x
CTTH ██% $4M x 5.3x
CTXR ██% $14M x 0.2x
CUE ██% $131M x 6.1x
CURX ██% $5M x 0.6x
CVKD ██% $6M x 3.6x
CVSI ██% $4M x 2.6x
CYCN ██% $15M x 2.2x
CYDY ██% $270M x x
CYPH ██% $67M x 0.8x
CYRX ██% $766M 9.6x 1.6x
CYTK ██% $10.95B x x
DARE ██% $19M x 26.2x
DCOY ██% $2M x 0.5x
DERM ██% $174M x 5.6x
DMAC ██% $363M x 7.7x
DMRA ██% $1.80B x 3.5x
DNTH ██% $5.70B x 4.8x
DRMA ██% $5M x 0.8x
DRUG ██% $706M x x
DSGN ██% $742M x 3.4x
DWTX ██% $51M x 0.6x
DYN ██% $4.23B x 4.9x
EBS ██% $380M x 0.7x
EDSA ██% $48M x 4.7x
ELAB ██% $4M x 0.3x
ELAN ██% $12.69B x 2.0x
ELDN ██% $271M x 6.1x
ELTP ██% $409M 9.1x 4.1x
ELTX ██% $79M x x
ELVN ██% $3.77B x 8.3x
EMMA ██% $820K x x
ENLV ██% $72M 0.0x 0.0x
ENSC ██% $4M x x
ENTA ██% $370M x 3.2x
ENVB ██% $5M x 1.1x
EOLS ██% $401M x x
EPRX ██% $403M x 4.9x
EQ ██% $149M x 2.5x
ERAS ██% $6.55B x 16.6x
ERNA ██% $5M x 0.7x
ESPR ██% $799M x x
ETON ██% $1.16B x 37.8x
ETST ██% $35M 7.2x 5.0x
EVFM ██% $1M x x
EVMN ██% $413M x 1.4x
EWTX ██% $4.35B x 8.8x
FBIO ██% $109M 0.9x 0.7x
FBLG ██% $3M x 1.3x
FBRX ██% $1.57B x 37.3x
FHTX ██% $305M x x
FLNA ██% $44M x 0.6x
FTH ██% $754M x x
FULC ██% $248M x 0.7x
GALT ██% $223M x x
GANX ██% $79M x 5.6x
GCAN ██% $260K x x
GDTC ██% $11M x x
GERN ██% $956M x 4.2x
GHRS ██% $1.73B x x
GLMD ██% $3M x 0.2x
GLSI ██% $197M x 37.4x
GNLX ██% $132M x 5.8x
GNPX ██% $4M x 0.2x
GOSS ██% $97M x x
GOVX ██% $4M x 2.3x
GPCR ██% $3.46B x 2.4x
GRCE ██% $38M x 0.6x
GRI ██% $2M x 0.2x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $104.11B x x
GTBP ██% $12M x 1.6x
GYRE ██% $683M x 6.8x
HCM ██% $1.92B 2.1x 1.6x
HCWB ██% $4M x 0.8x
HELP ██% $477M x x
HEPA ██% $1M x 0.7x
HIND ██% $14M x 2.1x
HOOK ██% $14M x 0.4x
HOWL ██% $22M x 1.8x
HRMY ██% $2.06B 14.2x 2.3x
HRTX ██% $87M x 9.6x
HSTC ██% $99M x 79.9x
HURA ██% $141M x 6.1x
HYFT ██% $67M x x
HYPD ██% $39M x 0.7x
IBIO ██% $72M x 0.9x
IBO ██% $47M x 4.1x
IDYA ██% $3.16B x 3.4x
IFRX ██% $250M x x
IGC ██% $26M x 4.2x
IMMP ██% $56M x x
IMMX ██% $619M x 7.3x
IMNM ██% $2.56B x 4.3x
IMNN ██% $6M x 1.8x
IMRN ██% $9M x x
IMRX ██% $282M x 1.4x
IMUX ██% $188M x 1.2x
INBP ██% $5M x 0.3x
INDP ██% $272M x 217.8x
INDV ██% $4.96B 19.7x x
INM ██% $9M x 1.3x
INO ██% $80M x 13.2x
INSM ██% $22.68B x 32.2x
INTI ██% $14M x x
INVA ██% $1.62B 3.2x 1.2x
IOBTQ ██% $70K x 0.1x
IONS ██% $9.28B x 18.9x
IRD ██% $277M x x
IRON ██% $2.82B x 4.1x
IRWD ██% $644M 6.3x x
ISCO ██% $2M x x
IVA ██% $1.09B x x
IXHL ██% $36M x 0.5x
JAGX ██% $5M x x
JANX ██% $948M x 1.0x
JAZZ ██% $15.81B 536.1x 3.5x
JBIO ██% $1.21B x 4.1x
JNJ ██% $640.25B 30.4x 7.5x
JUNS ██% $6M x x
KALA ██% $12M x 1.2x
KALV ██% $1.38B x x
KAPA ██% $7M x 1.3x
KAYS ██% $210K x x
KMDA ██% $403M x x
KNSA ██% $4.86B 66.5x 8.0x
KPRX ██% $10M x 0.7x
KPTI ██% $160M x x
KROS ██% $201M x 0.7x
KRRO ██% $155M x 1.3x
KTTA ██% $15M x 0.3x
KURA ██% $825M x 7.6x
KYNB ██% $29M 0.2x x
LAB ██% $300M 3.8x 0.5x
LBRX ██% $997M x 2.6x
LEGN ██% $3.73B x x
LEXX ██% $13M x 2.7x
LFCR ██% $163M x x
LFVN ██% $80M 10.2x 2.4x
LGND ██% $5.96B 38.8x 6.0x
LGVN ██% $19M x 1.2x
LIANY ██% $12M x 0.1x
LIFD ██% $3M x 0.4x
LIPO ██% $150K x 0.1x
LITS ██% $34M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.85B x x
LLY ██% $1.09T 43.3x 35.1x
LNAI ██% $10M x x
LPCN ██% $16M x 0.7x
LQDA ██% $7.46B 334.2x 68.7x
LRMR ██% $394M x 2.5x
LSTA ██% $13M x 1.2x
LTRN ██% $36M x 10.3x
LXRX ██% $994M x 4.9x
LYEL ██% $302M x 1.1x
MAIA ██% $78M x 2.8x
MANE ██% $4.65B x 11.9x
MBIO ██% $4M x 0.5x
MBRX ██% $15M x 1.0x
MBX ██% $2.92B x 6.7x
MCRB ██% $47M x 1.8x
MDCX ██% $18M x 13.6x
MDGL ██% $12.70B x 23.4x
MGNX ██% $254M x 12.0x
MIRA ██% $37M x 4.0x
MIRM ██% $6.96B x 28.7x
MIST ██% $133M x 3.7x
MLTX ██% $1.69B x 6.7x
MLYS ██% $2.24B x 3.5x
MNKD ██% $1.22B x x
MNOV ██% $65M x 1.7x
MNPR ██% $739M x 5.5x
MPLT ██% $448M x 1.1x
MREO ██% $48M x 1.4x
MRK ██% $323.24B 36.2x 7.1x
MRKR ██% $20M x 1.5x
MRVI ██% $2.47B x 11.7x
MSLE ██% $197M x x
MTNB ██% $2M x 0.7x
MTVA ██% $7M x 0.8x
NAMS ██% $3.52B x 5.3x
NATR ██% $362M 18.2x 2.2x
NBP ██% $206M x 0.8x
NBTX ██% $1.95B x x
NCEL ██% $19M x 35.7x
NCNA ██% $5M x x
NERV ██% $184M x x
NEUP ██% $21M x 0.7x
NGNE ██% $691M x 2.9x
NIKA ██% $806M x x
NKTR ██% $2.41B x 4.2x
NKTX ██% $168M x 0.6x
NMAD ██% $81M x 10.2x
NNVC ██% $39M x 4.3x
NRIX ██% $2.43B x 6.0x
NRSN ██% $21M x x
NRXP ██% $155M x x
NSRX ██% $36M x 13.1x
NTHI ██% $85M x x
NUVB ██% $2.31B x 7.2x
NUVL ██% $9.75B x 8.3x
NVCT ██% $616M x 43.3x
NVS ██% $297.88B x x
NWBO ██% $273M x x
NXTC ██% $21M x 0.8x
NXTS ██% $2M x 0.2x
OCUL ██% $1.89B x 3.3x
OGEN ██% $2M x 0.4x
OGI ██% $132M x x
OGN ██% $3.56B 14.5x 3.9x
OKUR ██% $164M x 0.9x
OLMA ██% $1.05B x 2.2x
OMER ██% $816M 9.5x x
ONC ██% $33.81B 65.9x 7.1x
ONCO ██% $3M x 0.3x
ONCY ██% $93M x x
OPK ██% $937M x 0.8x
ORGO ██% $328M 120.7x 1.3x
ORIC ██% $1.24B x 3.0x
ORKA ██% $5.44B x 11.2x
ORMP ██% $170M 1.6x 0.7x
OSTX ██% $70M x x
OTLC ██% $18M x 0.1x
OVID ██% $439M x 2.2x
OWPC ██% $70K x x
PAHC ██% $1.43B 15.0x 4.0x
PBH ██% $2.44B 12.8x 1.3x
PBM ██% $12M x x
PBYI ██% $407M 16.7x 3.2x
PCRX ██% $1.04B 202.5x 1.6x
PCSA ██% $7M x 2.7x
PCYN ██% $2M x 1.0x
PDSB ██% $39M x 9.9x
PEPG ██% $131M x 1.0x
PFE ██% $140.40B 18.7x 1.6x
PGEN ██% $1.93B x 95.3x
PHAT ██% $949M x x
PHIO ██% $12M x 0.7x
PHVS ██% $2.37B x x
PKTX ██% $3M x 10.3x
PLRX ██% $67M x 0.4x
PLYX ██% $93M x 37.3x
PMHS ██% $2M x x
PMN ██% $105M x 1.7x
PMVP ██% $63M x 0.7x
PPBT ██% $1M x x
PPCB ██% $3M x 0.3x
PRAX ██% $8.80B x 6.2x
PRFX ██% $3M x 0.4x
PRGO ██% $1.40B x 0.6x
PRLD ██% $321M x 5.3x
PRPH ██% $840K x 0.1x
PRQR ██% $244M x x
PRTA ██% $462M x 1.5x
PTCT ██% $6.28B x x
PTGX ██% $8.71B x 13.3x
PTIX ██% $420K x x
PTN ██% $14M x 1.3x
PTPI ██% $170K 0.0x 0.1x
PULM ██% $6M x 1.8x
PVCT ██% $25M x x
PVLA ██% $2.03B x 8.7x
PYXS ██% $183M x 5.9x
QNRX ██% $9M x 1.0x
QNTM ██% $19M x x
QTTB ██% $452M 13.6x 9.8x
QUCY ██% $25M x 5.5x
QURE ██% $2.41B x 16.1x
RADX ██% $29M x x
RANI ██% $111M x 3.9x
RAPP ██% $2.01B x 4.3x
RARE ██% $2.64B x x
RCKT ██% $355M x 1.5x
RCUS ██% $3.49B x 6.7x
RDY ██% $9.82B x x
REGN ██% $69.39B 15.7x 2.2x
REVB ██% $4M x 0.3x
RFL ██% $121M x 1.6x
RGBP ██% $50K x x
RIGL ██% $688M 1.9x 1.7x
RKTO ██% $17M x 4.1x
RLMD ██% $546M x 2.5x
RLYB ██% $86M x 1.7x
RMHI ██% $25M x x
RMTI ██% $29M x 0.8x
RNAC ██% $212M x x
RNAZ ██% $5M x 4.0x
RNTX ██% $67M x 5.8x
RNXT ██% $42M x 3.7x
ROIV ██% $25.01B x 5.5x
RPRX ██% $33.82B 40.9x 4.9x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $101M x 16.5x
RYTM ██% $7.26B x 59.1x
RZLT ██% $478M x 4.1x
SBFM ██% $2M x 0.1x
SCNX ██% $15M x 0.2x
SCYX ██% $284M x 6.9x
SDEV ██% $30M 0.1x 0.2x
SDGR ██% $1.13B x 3.6x
SEPN ██% $1.50B x 4.0x
SER ██% $31M x 1.8x
SGMT ██% $460M x 4.5x
SHPH ██% $2M x 0.5x
SIGA ██% $222M 11.0x 1.5x
SILO ██% $5M x 0.9x
SION ██% $2.05B x 7.1x
SKVI ██% $1M x x
SKYE ██% $22M x 2.4x
SLGL ██% $259M x 11.4x
SLN ██% $570M x 11.5x
SLS ██% $1.97B x 18.3x
SMMT ██% $10.39B x 16.5x
SMNR ██% $145M x x
SNDX ██% $1.80B x 43.1x
SNGX ██% $5M x 1.7x
SNSE ██% $31M x x
SNY ██% $108.63B x x
SPRB ██% $116M x 3.3x
SPRC ██% $3M x x
SPRO ██% $70M 4.6x 1.3x
SPRY ██% $572M x 9.3x
SRPT ██% $1.67B 25.8x 1.1x
STOK ██% $1.85B x 4.7x
STTK ██% $670M x 7.0x
SUPN ██% $2.73B x 2.5x
SVRA ██% $1.10B x 6.2x
SXTP ██% $4M x 0.8x
SYBX ██% $7M x 0.6x
SYRE ██% $7.58B x 11.3x
TAK ██% $56.43B x x
TBPH ██% $870M 7.6x 3.0x
TCRT ██% $4M x 3.5x
TELO ██% $82M x 16.5x
TENX ██% $411M x 3.6x
TEVA ██% $36.52B 23.3x 4.4x
TGTX ██% $8.54B 18.5x 14.7x
TLPH ██% $63M x 3.4x
TLX ██% $3.41B x x
TNGX ██% $4.16B x 10.6x
TNXP ██% $161M x 0.7x
TOVX ██% $10M x 0.6x
TPST ██% $15M x 17.9x
TRDA ██% $228M x 0.8x
TRVI ██% $2.32B x 13.5x
TTRX ██% $238M x 38.9x
TVRD ██% $23M x 1.6x
TVTX ██% $5.16B x 52.2x
TXMD ██% $24M 131.9x 0.9x
TYRA ██% $1.85B x 4.8x
UNCY ██% $126M x 3.4x
UPB ██% $333M x 1.1x
URGN ██% $1.99B x x
UTHR ██% $26.28B 20.4x 4.5x
VBIO ██% $890K x 0.1x
VCNX ██% $3M x x
VERA ██% $2.40B x 4.8x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.84B x 7.6x
VNDA ██% $308M x 1.1x
VRCA ██% $99M x 6.2x
VRDN ██% $1.99B x 3.1x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $122.80B 28.3x 6.3x
VSTM ██% $542M x 6.6x
VTGN ██% $9M x 0.3x
VTRS ██% $20.60B x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $166M x 1.4x
WVE ██% $1.13B x 2.2x
XBIO ██% $6M x 0.8x
XBIT ██% $70M x 0.5x
XCUR ██% $10M x 5.0x
XENE ██% $6.29B x 4.7x
XERS ██% $1.43B 118.9x 109.8x
XLO ██% $60M x 0.8x
XNCR ██% $1.44B x 2.8x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $7M x x
ZBIO ██% $2.03B x 6.0x
ZLAB ██% $2.10B x 3.2x
ZNTL ██% $322M x 1.8x
ZTS ██% $32.57B 12.3x 10.1x
ZVRA ██% $568M 4.6x 2.8x
ZVSA ██% $940K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Beone Medicines Ltd. Stock Forecast

How accurate are Beone Medicines Ltd. stock predictions?

Our AI model shows a 8% Spearman correlation coefficient for ONC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Beone Medicines Ltd. stock price forecasts?

Our analysis considers Beone Medicines Ltd.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Beone Medicines Ltd. a good investment in 2025?

Based on our AI analysis, Beone Medicines Ltd. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Beone Medicines Ltd. forecasts updated?

Beone Medicines Ltd. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Beone Medicines Ltd.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...